Annovis Bio has been given the go-ahead by the U.S. Food and Drug Administration (FDA) to begin a Phase 3 clinical trial to test buntanetap (ANVS401) as an oral therapy for early-stage Parkinson’s disease. “With this FDA notice in hand, we are thrilled to start recruiting for the US clinical trial soon, expected later this summer,” Maria […]

Natural killer (NK) cells are an important component of immunity, for their ability to destroy cells infected with viruses as well as those containing cancer tumors. From the same family as T and B cells, they differ from T cells as they do not require an antigen to kill cancerous cells. US biotech company Cytovia […]

COVID-19 pandemic, the challenging capital-markets climate in biotech, and a more innovative and specialty treatment focus has increased reliance on the finance arm as a key strategic cog. Over the past three years, the pharmaceutical industry has gone through several impactful changes. During the early months of the COVID-19 pandemic, investors flooded the industry with […]